Tower Research Capital (TRC)’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80.9K | Sell |
29,647
-8,639
| -23% | -$23.6K | ﹤0.01% | 2556 |
|
|
2025
Q1 | $64.3K | Buy |
38,286
+23,150
| +153% | +$38.9K | ﹤0.01% | 2044 |
|
|
2024
Q4 | $24.7K | Buy |
15,136
+10,548
| +230% | +$17.2K | ﹤0.01% | 3037 |
|
|
2024
Q3 | $19.1K | Sell |
4,588
-14,001
| -75% | -$58.2K | ﹤0.01% | 3263 |
|
|
2024
Q2 | $101K | Buy |
18,589
+17,367
| +1,421% | +$94.8K | ﹤0.01% | 2570 |
|
|
2024
Q1 | $12.2K | Sell |
1,222
-32,885
| -96% | -$329K | ﹤0.01% | 3500 |
|
|
2023
Q4 | $139K | Buy |
34,107
+30,796
| +930% | +$126K | ﹤0.01% | 2375 |
|
|
2023
Q3 | $12.8K | Sell |
3,311
-8,732
| -73% | -$33.8K | ﹤0.01% | 3857 |
|
|
2023
Q2 | $71.8K | Buy |
12,043
+7,228
| +150% | +$43.1K | ﹤0.01% | 2269 |
|
|
2023
Q1 | $16K | Buy |
4,815
+3,337
| +226% | +$11.1K | ﹤0.01% | 3732 |
|
|
2022
Q4 | $5K | Sell |
1,478
-26,170
| -95% | -$88.5K | ﹤0.01% | 4904 |
|
|
2022
Q3 | $166K | Buy |
27,648
+13,284
| +92% | +$79.8K | ﹤0.01% | 2105 |
|
|
2022
Q2 | $92K | Buy |
14,364
+6,594
| +85% | +$42.2K | ﹤0.01% | 2362 |
|
|
2022
Q1 | $64K | Buy |
7,770
+376
| +5% | +$3.1K | ﹤0.01% | 2540 |
|
|
2021
Q4 | $115K | Buy |
7,394
+2,319
| +46% | +$36.1K | ﹤0.01% | 2150 |
|
|
2021
Q3 | $114K | Buy |
5,075
+1,609
| +46% | +$36.1K | ﹤0.01% | 2287 |
|
|
2021
Q2 | $68K | Buy |
3,466
+3,066
| +767% | +$60.2K | ﹤0.01% | 2761 |
|
|
2021
Q1 | $13K | Buy |
+400
| New | +$13K | ﹤0.01% | 4220 |
|